Literature DB >> 9580189

Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase: structure, catalytic mechanism and targeted inhibitor design.

D H Souza1, R C Garratt, A P Araújo, B G Guimarães, W D Jesus, P A Michels, V Hannaert, G Oliva.   

Abstract

The structure of the enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from glycosomes of the parasite Trypanosoma cruzi, causative agent of Chagas' disease, is reported. The final model at 2.8 A includes the bound cofactor NAD+ and 90 water molecules per monomer and resulted in an Rfactor of 20.1%, Rfree = 22.3%, with good geometry indicators. The structure has no ions bound at the active site resulting in a large change in the side chain conformation of Arg249 which as a consequence forms a salt bridge to Asp210 in the present structure. We propose that this conformational change could be important for the reaction mechanism and possibly a common feature of many GAPDH structures. Comparison with the human enzyme indicates that interfering with this salt bridge could be a new approach to specific inhibitor design, as the equivalent to Asp210 is a leucine in the mammalian enzymes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580189     DOI: 10.1016/s0014-5793(98)00154-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruzi.

Authors:  Irwin R A Menezes; Julio C D Lopes; Carlos A Montanari; Glaucius Oliva; Fernando Pavão; Marcelo S Castilho; Paulo C Vieira; Mônica T Pupo
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

2.  New drugs for neglected infectious diseases: Chagas' disease.

Authors:  Fabiana S Machado; Herbert B Tanowitz; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

3.  Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.

Authors:  A M Aronov; S Suresh; F S Buckner; W C Van Voorhis; C L Verlinde; F R Opperdoes; W G Hol; M H Gelb
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

4.  Role of Δ1-pyrroline-5-carboxylate dehydrogenase supports mitochondrial metabolism and host-cell invasion of Trypanosoma cruzi.

Authors:  Brian S Mantilla; Lisvane S Paes; Elizabeth M F Pral; Daiana E Martil; Otavio H Thiemann; Patricio Fernández-Silva; Erick L Bastos; Ariel M Silber
Journal:  J Biol Chem       Date:  2015-01-26       Impact factor: 5.157

5.  Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.

Authors:  J C Bressi; C L Verlinde; A M Aronov; M L Shaw; S S Shin; L N Nguyen; S Suresh; F S Buckner; W C Van Voorhis; I D Kuntz; W G Hol; M H Gelb
Journal:  J Med Chem       Date:  2001-06-21       Impact factor: 7.446

6.  Recombinant human sperm-specific glyceraldehyde-3-phosphate dehydrogenase (GAPDHS) is expressed at high yield as an active homotetramer in baculovirus-infected insect cells.

Authors:  David R Lamson; Alan J House; Polina V Danshina; Jonathan Z Sexton; Khaddijatou Sanyang; Deborah A O'Brien; Li-An Yeh; Kevin P Williams
Journal:  Protein Expr Purif       Date:  2010-09-07       Impact factor: 1.650

7.  Antileishmanial Activity of Lignans, Neolignans, and Other Plant Phenols.

Authors:  Jiří Pospíšil; Daniela Konrádová; Miroslav Strnad
Journal:  Prog Chem Org Nat Prod       Date:  2021

8.  Structure of NADP-dependent glyceraldehyde-3-phosphate dehydrogenase from Synechococcus PCC7942 complexed with NADP.

Authors:  Tomoya Kitatani; Yoshihiro Nakamura; Kei Wada; Takayoshi Kinoshita; Masahiro Tamoi; Shigeru Shigeoka; Toshiji Tada
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-03-10

9.  Role of cytosolic glyceraldehyde-3-phosphate dehydrogenase in visceral organ infection by Leishmania donovani.

Authors:  Wen-Wei Zhang; Laura-Isobel McCall; Greg Matlashewski
Journal:  Eukaryot Cell       Date:  2012-11-02

10.  Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donors.

Authors:  Jean Jerley N Silva; Wander R Pavanelli; José Clayston M Pereira; João S Silva; Douglas W Franco
Journal:  Antimicrob Agents Chemother       Date:  2009-07-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.